Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2005 April;96(2) > Minerva Medica 2005 April;96(2):77-86

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

REVIEWS  


Minerva Medica 2005 April;96(2):77-86

language: Italian

Brain natriuretic peptide and heart failure

Camici M.


PDF  


Heart failure is analysed following the recent classification (prognostic and symptomatic: 4 stages) proposed by the American Heart Association (AHA). The study is focused on the first stage (Stage A) of the AHA classification where the patient is asymptomatic, without heart structural abnormalities but at risk to develop heart failure. In Stage A neurohumural mechanisms of heart failure such as natriuretic peptide system are activated. The author analyses the links between heart failure and the natriuretic peptide system and the role played by the plasma level of brain natriuretic peptide as biomarker of heart failure in Stage A.

top of page

Publication History

Cite this article as

Corresponding author e-mail